Definitive Contract HHSD200201796258C
- Not listed
- This is a definitive, firm-fixed-price contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to The Ohio State University for the "OHIO STATE ORGANISMS & GENES STUDY." The contract, which does not have a set-aside designation, was awarded on September 30, 2018 with a potential value of $385,853.00 and a completion date of December 31, 2019. As a public research university, The Ohio State University has a history of...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $155,333.00 definitive contract to The Ohio State University to conduct a study on antibiotic stewardship under a Broad Agency Announcement (BAA). The contract is a cost-no-fee arrangement with a completion date of February 29, 2020. The Ohio State University, a public research university, has experience conducting a variety of federally funded research and support services for agencies such as the...
- This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Ohio State University in the amount of $630,103.00. The contract has a firm fixed price pricing type and a completion date of April 30, 2023. It was awarded on August 1, 2020 and does not have a set-aside designation. The contract is for FY20 BAA TOPIC 5.5 and the place of performance is Chamblee, Georgia. The Ohio State University is a public research university...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to The Ohio State University to study and test a heptavalent combination vaccine in gnotobiotic piglets. The $249,717.00 contract has an August 21, 2021 completion date and was awarded on August 22, 2019. The Ohio State University is a public research university that has extensive experience conducting research and providing services to federal agencies through both...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $234,400.00 firm fixed price purchase order to The Ohio State University for the testing of gnotobiotic piglets. The contract has a completion date of December 31, 2022 and was awarded on July 23, 2020. The Ohio State University is a public research university that has a history of providing various goods and services to federal agencies through prime contracts and subcontracts, including...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order for $248,948.00 to The Ohio State University to provide scientific services related to Salmonella research. The contract, which has a completion date of September 29, 2022, was awarded on September 30, 2020 and does not have a set-aside designation. The Ohio State University, as a public research university, has extensive experience conducting scientific research and...
- This is a $473,312 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Ohio State University to prevent the dissemination of carbapenem-resistant Enterobacteriaceae (CRE). The contract has a period of performance from September 15, 2016 to September 29, 2017 and is a cost-no-fee contract. The Ohio State University has previously received other federal contract awards and grants, including work for the National Institutes of Health, NASA, the Drug...
- This is a $2,455,612.00 federal contract award to The Ohio State University (OSU) by the National Heart Lung and Blood Institute, a civilian agency within the U.S. government. The contract is for the Women's Health Initiative (WHI) Regional Center, specifically covering Task Areas A and A2. It is a delivery order contract with a cost-no-fee pricing type and a performance period ending on January 31, 2028. The contract does not have a set-aside designation. As a prominent public research...
- This is a firm fixed-price purchase order contract awarded by the Washington Headquarters Service, a defense agency, to The Ohio State University in the amount of $123,636.00. The contract is for graduate research support services and does not have a set-aside designation. The Ohio State University has a history of providing various goods and services to federal agencies, including coordination and support services for clinical trials related to women's health, infrastructure support for NASA...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to The Ohio State University (OSU) for the testing of parenterally administered live attenuated rotavirus, with a completion date of September 5, 2025 and a ceiling value of $248,005.00. The contract does not have a set-aside designation. OSU is a public research university that has a history of providing various goods and services to federal agencies, including coordination and support...
The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a definitive cost-no-fee contract valued at $693,598.00 to The Ohio State University (OSU) on September 29, 2017. The contract, which does not have a set-aside designation, is for unspecified "other functions" and is scheduled for completion on March 31, 2019. OSU, through its Office of Sponsored Programs, has previously provided various goods and services to federal agencies, including coordination and support services for women's health clinical trials for the National Institutes of Health (NIH), infrastructure support for NASA's space exploration efforts, and technical services for the Department of Defense. OSU also holds an indefinite delivery contract with the NIH's National Heart, Lung and Blood Institute to serve as a Women's Health Initiative Regional Center, providing coordination and support for ongoing studies related to preventing heart disease, cancer, and fractures in postmenopausal women.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Preventing the dissemination of CRE from healthcare facilities into surface waters in the US | CDCBAAFY2017-OADS-01-96258 | Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services | Award Notice 1/1 | 10/6/17, 11:52 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 2 | Other Administrative Action | $0 | 5/11/18 | |
| 1 | Other Administrative Action | $0 | 10/27/17 | |
| Not listed | Not listed | $693.6k | 9/27/17 |